Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds
Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence
Age Doesn’t Affect Survival After Bone Marrow Transplant
Lenalidomide Found Effective For Lymphoma In Phase II Trial
Intensive Chemo Equivalent To Transplant For MCL
Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant
Arzerra Promising For Heavily Pre-Treated CLL Patients
Dismissed Leukemia Drug Helps CLL, Clinical Trials Find
PDX Shows 27% Response In T-Cell Lymphoma In Study
Second-Generation CML Drugs Show Promise For Frontline
Gleevec To Prevent Recurrence Of Gastrointestinal Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?
- Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out